Enhancer remodeling promotes tumor-initiating activity in NRF2-activated non-small cell lung cancers
Aberrant activation of NRF2 in cancer cells contributes to tumorigenicity and therapeutic resistance. Here, the authors show that NRF2 cooperates with CEBPB and remodels enhancers to confer tumor-initiating activity on NRF2- activated non-small cell lung cancers.
Guardado en:
Autores principales: | Keito Okazaki, Hayato Anzawa, Zun Liu, Nao Ota, Hiroshi Kitamura, Yoshiaki Onodera, Md. Morshedul Alam, Daisuke Matsumaru, Takuma Suzuki, Fumiki Katsuoka, Shu Tadaka, Ikuko Motoike, Mika Watanabe, Kazuki Hayasaka, Akira Sakurada, Yoshinori Okada, Masayuki Yamamoto, Takashi Suzuki, Kengo Kinoshita, Hiroki Sekine, Hozumi Motohashi |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Nature Portfolio
2020
|
Materias: | |
Acceso en línea: | https://doaj.org/article/e2fd0ce97bcb4b3aabb6a909e9e673dd |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Publisher Correction: Enhancer remodeling promotes tumor-initiating activity in NRF2-activated non-small cell lung cancers
por: Keito Okazaki, et al.
Publicado: (2021) -
Activation of the NRF2 pathway in Keap1-knockdown mice attenuates progression of age-related hearing loss
por: Tetsuya Oishi, et al.
Publicado: (2020) -
Genetic loci for lung function in Japanese adults with adjustment for exhaled nitric oxide levels as airway inflammation indicator
por: Mitsuhiro Yamada, et al.
Publicado: (2021) -
Antiviral Activity and Underlying Action Mechanism of Euglena Extract against Influenza Virus
por: Ayaka Nakashima, et al.
Publicado: (2021) -
Nrf2 suppresses macrophage inflammatory response by blocking proinflammatory cytokine transcription
por: Eri H. Kobayashi, et al.
Publicado: (2016)